loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 20329 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PFIZER (3)

filter

01 TABLET, EXTENDED RELEASE;ORAL (3)

filter

01 RX (3)

filter

01 GLUCOTROL XL (3)

filter

01 Yes (3)

URL Supplier Web Content
TABLET, EXTENDED R...
10MG
1994-04-26
20329
GLUCOTROL XL
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
2.5MG
1999-08-10
20329
GLUCOTROL XL
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
5MG
1994-04-26
20329
GLUCOTROL XL
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 20329

Looking for FDA Orange Book APPLICATION 20329 3

19

Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is GLIPIZIDE, with a corresponding application number 20329.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 1994-04-26

Therapeutic Equivalence (TE) Code AB

18

Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is GLIPIZIDE, with a corresponding application number 20329.

Regulatory Information RX

With a dosage strength 2.5MG

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 1999-08-10

Therapeutic Equivalence (TE) Code AB

17

Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is GLIPIZIDE, with a corresponding application number 20329.

Regulatory Information RX

With a dosage strength 5MG

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 1994-04-26

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY